|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Loss on extinguishment of debt | |||||
| Gain on settlement of liabilities | |||||
| Changes in operating assets and liabilities | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Net Cash used in Operating Activities | |||||
| Financing Activities | |||||
| Proceeds from issuance of common stock and warrants – net of issuance costs | |||||
| Proceeds from issuance of common stock and warrants | |||||
| Proceeds from issuance of notes payable | |||||
| Proceeds from issuance of notes payable, related party | |||||
| Repayment of notes payable, related party | |||||
| Net Cash provided by Financing Activities | |||||
| Net Change in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents at Beginning of Period | |||||
| Cash and Cash Equivalents at End of Period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non Cash Financing & Investing Activities, and Other Disclosures | |||||
| Issued warrants as debt issuance costs | |||||
| Warrants issued in connection with debt issuances | |||||
Loading...